Analysis of T Cell Metabolism in Relapsed AML Patients With DLIs and Bicanorm Treatment
Status:
Completed
Trial end date:
2020-03-18
Target enrollment:
Participant gender:
Summary
In this study, the outcomes of relapsed AML patients receiving DLIs and Bicanorm (Sodium
bicarbonate) were analyzed including T cell metabolism and immune phenotype.